|Over a month ago|
Fly Intel: After Hours Movers » 19:0502/1802/18/20
QUAD, SSTI, ENPH, HLF, SCPL, LZB, RPAI, XPER, FANG, DVN, TPH, TIVO, BBBY, GRPN, KNL, SGMS, APRN, AMED, BKD, TXG, LC, PLMR, BLUE, HSTM, KAR
UP AFTER EARNINGS:…
UP AFTER EARNINGS: Quad/Graphics (QUAD) up 25.0%... ShotSpotter (SSTI) up 20.1%... Enphase Energy (ENPH) up 11.8%... Herbalife (HLF) up 5.8%... SciPlay (SCPL) up 4.7%... La-Z-Boy (LZB) up 4.6%... Retail Properties of America (RPAI) up 3.0%... Xperi (XPER) up 2.5%... Diamondback Energy (FANG) up 1.9%... Devon Energy (DVN) up 1.9%... TriPointe Group (TPH) up 1.9%... TiVo (TIVO) up 1.5%. ALSO HIGHER: Bed Bath Beyond (BBBY) up 4.0% after guiding FY20 capital allocation. DOWN AFTER EARNINGS: Groupon (GRPN) down 24.9%... Knoll (KNL) down 13.6%... Scientific Games (SGMS) down 10.5%... Blue Apron (APRN) down 9.8%... Amedisys (AMED) down 9.0%... Brookdale Senior Living (BKD) down 6.4%... 10X Genomics (TXG) down 5.1%... LendingClub (LC) down 2.8%... Palomar (PLMR) down 2.8%... bluebird bio (BLUE) down 2.0%... HealthStream (HSTM) down 1.4%... KAR Auction Services (KAR) down 1.4%. Movers as of 18:30ET.
SciPlay reports Q4 payer conversion rates remained strong at 6.0% » 16:0302/1802/18/20
In Q4: Average monthly…
In Q4: Average monthly revenue per paying user increased 15.3% to $88.06. ARPDAU increased 8.7% from the prior year period to 50c. Mobile penetration increased 300 basis points from the prior year to 84%.
SciPlay reports Q4 EPS 19c, consensus 22c » 16:0202/1802/18/20
Reports Q4 revenue…
Reports Q4 revenue $112.9M, consensus $121.12M.
SciPlay initiated with a Buy at DA Davidson » 07:1701/2201/22/20
DA Davidson analyst…
DA Davidson analyst Franco Granda initiated coverage of SciPlay with a Buy rating and $15 price target. The analyst cites the company's leading position as a developer of social casino mobile gaming and sees the stock offering best-in-class margins, an attractive game portfolio, and the potential for "organic and inorganic expansion of geographic regions and genres." Granda contends that SciPlay's growth story is in its early innings and anticipates meaningful revenue ramp ahead.
SciPlay initiated with a Hold at SunTrust » 16:1901/0601/06/20
SunTrust analyst Matthew…
SunTrust analyst Matthew Thornton initiated coverage of SciPlay (SCPL) with a Hold rating and $13 price target. While the company, which was recently spun-out of parent Scientific Games (SGMS), provides a near pure-play exposure to the large and growing mobile gaming market, he views consensus expectations as appropriate and thinks the fact that the parent has voting control and its higher game concentration warrant a valuation discount.
|Over a quarter ago|
Opening Day: 2019 IPOs in review » 08:3012/2212/22/19
UBER, LYFT, SDC, BBIO, WE, PTON, SGMS, SCPL, DOYU, PGNY, TW, TXG, ZM, LK
2019 had some big names…
Fly Intel: Top five analyst downgrades » 10:0812/1712/17/19
PNR, AA, GRPN, SCPL, LEN, DHI, FBHS, ALXN
Catch up on today's…
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Pentair (PNR) downgraded to Hold from Buy at Stifel with analyst Nathan Jones saying Pentair's 2020 prospects look improved over 2019 where discrete headwinds, particularly in the Aquatics business, create easy comparisons in the first half of 2020. 2. Alcoa (AA) downgraded to Market Perform from Outperform at BMO Capital with analyst David Gagliano saying BMO's reduced aluminum price forecasts for the entirety of the aluminum supply chain leave "little incremental upside potential" moving forward in the underlying price forecasts. 3. SciPlay (SCPL) was double downgraded to Sell from Buy at Goldman Sachs while Groupon (GRPN) was downgraded to Sell from Neutral. 4. Lennar (LEN) and Fortune Brands (FBHS) were downgraded to Sector Perform from Outperform at RBC Capital while D.R. Horton (DHI) was downgraded to Underperform from Sector Perform. 5. Alexion (ALXN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Matthew Harrison saying while he thinks the company can effectively transition Soliris to Ultomiris and maintain its large and emerging neurology franchise, he does not see the "major overhang of concentration risk" as one the company will be able to address in the near-term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SciPlay double-downgraded to Sell from Buy at Goldman Sachs » 06:1012/1712/17/19
Goldman Sachs analyst…
Goldman Sachs analyst Michael Ng double-downgraded SciPlay to Sell from Buy with a price target of $10, down from $12. The analyst is citing "stagnant bookings" of the 88 Fortunes, Quick Hit, Gold Fish, and Hot Shot Casino slot portfolio along with "slowing momentum" for Bingo and Monopoly lines, suggesting that the company's transition toward emerging casual games "not based on real world slot machines" may be more difficult than originally anticipated.
SciPlay downgraded to Sell from Buy at Goldman Sachs » 05:1512/1712/17/19
Goldman Sachs analyst…
Goldman Sachs analyst Michael Ng double downgraded SciPlay to Sell from Buy with a $10 price target on lower confidence in the company's slots portfolio..
RBC Capital to hold a conference » 04:5511/2011/20/19
ETSY, VRNS, BKNG, PFPT, TRUP, CTSH, WIX, LOGM, AKAM, ASML, BB, TREE, TYL, OTEX, JCOM, CDNS, VZ, ZG, SCPL
Technology, Internet, Media & Telecommunications Conference to b e held in New York on November 19-20.